AbbVie Inc. (NYSE:ABBV): AbbVie Could be Under Selling Pressure On Earnings Concerns

 


AbbVie stock has been under selling pressure since last week after CEO Richard Gonzalez told analysts at the JPMorgan Healthcare Conference on Jan 11 that the company's performance could be affected near term due to the loss of exclusivity of Humira. He did not anticipate a decline in 2024 earnings, however, per CNBC.

Investors may get more clarity on forecasts for sales of the two Humira successor drugs, Skyrizi and Rinvoq, on Feb 9 when AbbVie reports its 4Q22 earnings result. Meanwhile, the stock could be heading down to retest $138.25.

This note contained herein is not and should not be construed as a recommendation to buy or sell. Click here to view the latest update!

Comments

Post a Comment

Popular posts from this blog

TESLA INC. (NASDAQ:TSLA): A robotaxi war may be brewing in China

Image
Tesla cleared their first hurdles in China after the company received FSD approval from the Chinese government. Beware though, just days after Elon Musk confirmed Tesla's intent to unveil their robotaxi in August, one of China's largest ride-hailing companies, Didi Chuxing, announced a joint venture with Chinese EV maker GAC Aion to mass produce its own Level 4 robotaxi, per IOT World Today. Didi acquired Uber China in 2016 and has more than 80 million active users in China. The downtrend of Tesla stock remains intact. TSLA needs to break above the key resistance level at $182.33 soon, or else the stock could pull back to below its 50-day EMA. This note contained herein is our opinion and should not be construed as a recommendation to buy or sell. Click here to view the latest update!
Read more

BITCOIN (BTC/USD): Bitcoin stuck under trendline resistances at ~ 69k or the Nov'21 high

Image
Bitcoin is stuck under trendline resistances at ~ 69k, or the Nov'21 high. June's macro conditions could provide the next catalyst for bitcoin to make a breakout, per CoinDesk. Be aware, though, that a rejection from the trendline resistances could send bitcoin back down to retest the trendline support ~ 65k. This note contained herein is not and should not be construed as a recommendation to buy or sell. Click here to view the latest update!
Read more